DG
68
-10
CVS
32
-9
DE
42
-3
APH
58
2
ADSK
62
-4
CAT
73
-3
VIX
43
8
AN
61
-2
CHRW
71
-5
AVGO
33
2
MAC
60
-2
BDX
55
-5
DHI
33
-6
A
44
-3
CHD
31
-4
EMC
80
20
ABT
36
-3
BBY
38
-12
AFL
39
-2
CLX
50
-3
DG
68
-10
CVS
32
-9
DE
42
-3
APH
58
2
ADSK
62
-4
CAT
73
-3
VIX
43
8
AN
61
-2
CHRW
71
-5
AVGO
33
2
MAC
60
-2
BDX
55
-5
DHI
33
-6
A
44
-3
CHD
31
-4
EMC
80
20
ABT
36
-3
BBY
38
-12
AFL
39
-2
CLX
50
-3
Financhill
Back

Structure Therapeutics, Inc. 10K Form

Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.99
Seasonality Move:
-31.39%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive GPCR News And Ratings

See the #1 stock for the next 7 days that we like better than GPCR

GPCR Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-52.6M
Price / Cash Flow: 0
Annual Sales: $12.69
Price / Book: 5.23

Profitability

EPS (TTM): -3.65250
Net Income (TTM): $-210.9M
Gross Margin: $-2.6M
Return on Equity: -25.55%
Return on Assets: -24.24%

Structure Therapeutics, Inc. Earnings Forecast

Key Structure Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 5 years have been positive in 1 years.

Structure Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: GPCR
Website: structuretx.com

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 14.15
Quick Ratio: 13.89

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GPCR Technical Analysis vs Fundamental Analysis

Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy or a Sell?